A comparison of basal and eye-flush tears for the analysis of cat tear proteins

Acta Ophthalmologica

Volumn 89, Issue 1, 2011, Pages

  Petznick, Andrea ^a   Evans, Margaret D M ^a   Madigan, Michele C ^b,c   Markoulli, Maria ^b,d   Garrett, Qian ^b,e   Sweeney, Deborah F ^a,f  

^a VISION COOPERATIVE RESEARCH CENTRE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CSIRO   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e BRIEN HOLDEN VISION INSTITUTE   (Australia)

^f UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

cat; epithelial debridement; IgA; MMP; tear proteins; tears

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN A; TEAR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BICINCHONINIC ACID; CAT; CONTROLLED STUDY; CORNEA INJURY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LACRIMAL FLUID; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; CATS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; IMMUNOGLOBULIN A; MALE; MATRIX METALLOPROTEINASE 9; SPECIMEN HANDLING; TEARS;

EID: 79551514000     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.02082.x     Document Type: Article

References (49)

1. Allansmith MR, Radl J, Haaijman JJ, &, Mestecky J, (1985): Molecular forms of tear IgA and distribution of IgA subclasses in human lacrimal glands. J Allergy Clin Immunol 76: 569-576.
2. Barro CD, Romanet JP, Fdili A, Guillot M, &, Morel F, (1998): Gelatinase concentration in tears of corneal-grafted patients. Curr Eye Res 17: 174-182.
3. Baum JL, (1999): Basal vs reflex lacrimation. Arch Ophthalmol 117: 141.
4. Bjerrum KB, &, Prause JU, (1994): Collection and concentration of tear proteins studied by SDS gel electrophoresis. Presentation of a new method with special reference to dry eye patients. Graefes Arch Clin Exp Ophthalmol 232: 402-405.
5. Caffery B, Joyce E, Boone A, Slomovic A, Simpson T, Jones L, &, Senchyna M, (2008): Tear lipocalin and lysozyme in Sjogren and non-Sjogren dry eye. Optom Vis Sci 85: 661-667.
6. Carter RT, Kambampati R, Murphy CJ, &, Bentley E, (2007): Expression of matrix metalloproteinase 2 and 9 in experimentally wounded canine corneas and spontaneous chronic corneal epithelial defects. Cornea 26: 1213-1219.
7. Chotikavanich S, de Paiva CS, Li de Q, Chen JJ, Bian F, Farley WJ, &, Pflugfelder SC, (2009): Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 50: 3203-3209.
8. Fullard RJ, &, Snyder C, (1990): Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest Ophthalmol Vis Sci 31: 1119-1126.
9. Fullard RJ, &, Tucker DL, (1991): Changes in human tear protein levels with progressively increasing stimulus. Invest Ophthalmol Vis Sci 32: 2290-2301.
10. Gipson IK, (2007): The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture. Invest Ophthalmol Vis Sci 48: 4390.
11. Gipson IK, &, Kiorpes TC, (1982): Epithelial sheet movement: protein and glycoprotein synthesis. Dev Biol 92: 259-262.
12. Helper LC, Magrane WG, Koehm J, &, Johnson R, (1974): Surgical induction of keratoconjunctivitis sicca in the dog. J Am Vet Med Assoc 165: 172-174.
13. Holly FJ, &, Lemp MA, (1977): Tear physiology and dry eyes. Surv Ophthalmol 22: 69-87.
14. Jordan A, &, Baum J, (1980): Basic tear flow. Does it exist? Ophthalmology 87: 920-930.
15. Josephson AS, &, Weiner RS, (1968): Studies of the proteins of lacrimal secretions. J Immunol 100: 1080-1081.
16. Kim HS, Luo L, Pflugfelder SC, &, Li DQ, (2005): Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells. Invest Ophthalmol Vis Sci 46: 840-848.
17. Kwok S, &, Madigan M, (1986): A new analysis of wound closure kinematics in the cat and rabbit corneal epithelium. Clin Exp Optom 96: 4-12.
18. Leonardi A, Sathe S, Bortolotti M, Beaton A, &, Sack R, (2009): Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. Allergy 64: 710-717.
19. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, &, Pflugfelder SC, (2004): Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 45: 4293-4301.
20. Manicone AM, &, McGuire JK, (2008): Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 19: 34-41.
21. McClellan BH, Whitney CR, Newman LP, &, Allansmith MR, (1973): Immunoglobulins in tears. Am J Ophthalmol 76: 89-101.
22. McLaughlin SA, Brightman AH, Helper LC, Primm ND, Brown MG, &, Greeley S, (1988): Effect of removal of lacrimal and third eyelid glands on Schirmer tear test results in cats. J Am Vet Med Assoc 193: 820-822.
23. Ng V, Cho P, Mak S, &, Lee A, (2000): Variability of tear protein levels in normal young adults: between-day variation. Graefes Arch Clin Exp Ophthalmol 238: 892-899.
24. Ng V, Cho P, Wong F, &, Chan Y, (2001): Variability of tear protein levels in normal young adults: diurnal (daytime) variation. Graefes Arch Clin Exp Ophthalmol 239: 257-263.
25. Ollivier FJ, Brooks DE, van Setten GB, et al. (2004): Profiles of matrix metalloproteinase activity in equine tear fluid during corneal healing in 10 horses with ulcerative keratitis. Vet Ophthalmol 7: 397-405.
26. Ollivier FJ, Gilger BC, Barrie KP, Kallberg ME, Plummer CE, O'Reilly S, Gelatt KN, &, Brooks DE, (2007): Proteinases of the cornea and preocular tear film. Vet Ophthalmol 10: 199-206.
27. Sack RA, Tan KO, &, Tan A, (1992): Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest Ophthalmol Vis Sci 33: 626-640.
28. Saito A, Izumisawa Y, Yamashita K, &, Kotani T, (2001): The effect of third eyelid gland removal on the ocular surface of dogs. Vet Ophthalmol 4: 13-18.
29. Sakimoto T, Shoji J, Yamada A, &, Sawa M, (2007): Upregulation of matrix metalloproteinase in tear fluid of patients with recurrent corneal erosion. Jpn J Ophthalmol 51: 343-346.
30. Sand B, Jensen OL, Eriksen JS, &, Vinding T, (1986): Changes in the concentration of secretory immunoglobulin A in tears during post-operative inflammation of the eye. Acta Ophthalmol (Copenh) 64: 212-215.
31. Schirmer O, (1903): Studien zur Physiologie und Pathologie der Tränenabsonderung und Tränenabfuhr. Graefes Arch Clin Exp Ophthalmol 56: 197-291.
32. Sen DK, &, Sarin GS, (1979): Immunoglobulin concentrations in human tears in ocular diseases. Br J Ophthalmol 63: 297-300.
33. van Setten GB, Salonen EM, Vaheri A, Beuerman RW, Hietanen J, Tarkkanen A, &, Tervo T, (1989): Plasmin and plasminogen activator activities in tear fluid during corneal wound healing after anterior keratectomy. Curr Eye Res 8: 1293-1298.
34. Sivak JM, &, Fini ME, (2002): MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 21: 1-14.
35. Smith VA, Khan-Lim D, Anderson L, Cook SD, &, Dick AD, (2008): Does orally administered doxycycline reach the tear film? Br J Ophthalmol 92: 856-859.
36. Song XJ, Li DQ, Farley W, Luo LH, Heuckeroth RO, Milbrandt J, &, Pflugfelder SC, (2003): Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 44: 4223-4229.
37. Soontornvipart K, Rauser P, Kecova H, &, Lexmaulova L, (2003): Effect of anaesthetic premedication with medetomidine-buprenorphine on the aqueous tear production in dogs. Acta Vet Brno 72: 267-272.
38. Spurr-Michaud S, Argüeso P, &, Gipson IK, (2007): Assay of mucins in human tear fluid. Exp Eye Res 84: 939-950.
39. Stapleton F, Willcox MD, Morris CA, &, Sweeney DF, (1998): Tear changes in contact lens wearers following overnight eye closure. Curr Eye Res 17: 183-188.
40. Sullivan DA, &, Allansmith MR, (1984): Source of IgA in tears of rats. Immunology 53: 791-799.
41. Sullivan DA, &, Allansmith MR, (1988): The effect of aging on the secretory immune system of the eye. Immunology 63: 403-410.
42. Tan KO, Sack RA, Holden BA, &, Swarbrick HA, (1993): Temporal sequence of changes in tear film composition during sleep. Curr Eye Res 12: 1001-1007.
43. Tervo T, Virtanen T, Honkanen N, Harkonen M, &, Tarkkanen A, (1994): Tear fluid plasmin activity after excimer laser photorefractive keratectomy. Invest Ophthalmol Vis Sci 35: 3045-3050. (Pubitemid 24186406)
44. Thörig L, van Agtmaal EJ, Glasius E, Tan KL, &, van Haeringen NJ, (1985): Comparison of tears and lacrimal gland fluid in the rabbit and guinea pig. Curr Eye Res 4: 913-920.
45. Van Haeringen NJ, (1981): Clinical biochemistry of tears. Surv Ophthalmol 26: 84-96.
46. Vesaluoma MH, &, Tervo TT, (1998): Tenascin and cytokines in tear fluid after photorefractive keratectomy. J Refract Surg 14: 447-454.
47. Vesaluoma M, Teppo AM, Gronhagen-Riska C, &, Tervo T, (1997): Increased release of tumour necrosis factor-alpha in human tear fluid after excimer laser induced corneal wound. Br J Ophthalmol 81: 145-149.
48. Visse R, &, Nagase H, (2003): Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839.
49. Yasueda S, Yamakawa K, Nakanishi Y, Kinoshita M, &, Kakehi K, (2005): Decreased mucin concentrations in tear fluids of contact lens wearers. J Pharm Biomed Anal 39: 187-195.